To investigate the effect of tumor cells on the p53 pathway in surrounding cells, the authors implanted an EO77 mammary carcinoma cell line that harbors mutant p53 into syngeneic host mice expressing wild-type p53. This evidence concerns the gene TP53 and breast carcinoma.